CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancer
Iris Lodewijk(Hospital Universitario 12 De Octubre), Marta Dueñas(Universidad Complutense de Madrid), Lucía Parrilla, Álvaro Martín de Bernardo, Esther Montesinos, Gottfrid Sjödahl(Lund University), Jesús M. Paramio(Universidad Complutense de Madrid), Cristian Suárez-Cabrera(Research Institute Hospital 12 de Octubre), Lucía Morales, Ignacio A. Reina(Research Institute Hospital 12 de Octubre), Carolina Rubio(Universidad Complutense de Madrid), Félix Guerrero-Ramos(Hospital Universitario 12 De Octubre), Rosa García-Martin(Hospital Universitario 12 De Octubre), Daniel Castellano(Hospital Universitario 12 De Octubre), Miguel Alonso-Sánchez(Research Institute Hospital 12 de Octubre), José L. Rodríguez-Peralto(Hospital Universitario 12 De Octubre), Rebeca Sánchez-Domínguez(Centre for Biomedical Network Research on Rare Diseases), Laura García-Gómez(Research Institute Hospital 12 de Octubre), Mercedes Pérez-Escavy(Research Institute Hospital 12 de Octubre), Pontus Eriksson(Lund University), Omaira Alberquilla(Cipher Gene (China))
Cited by 0
Related Papers
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386
Molecular classification of urothelial carcinoma: global <scp>mRNA</scp> classification versus tumour‐cell phenotype classification
|The Journal of Pathology|2017|368